In addition, Zhang et al. (2024) showed that the effective density of CD8+ cells in tumor samples from patients with NSCLC undergoing anti-PD1/PD-L1 therapy did not correlate with the OS, whereas a more specific HPK1+ PD1+ TIM3+ CD8+ subset indicated a negative correlation [84]. The gene discussed is MAP4K1; the disease is neoplasm.